On August 25, AVDX signed a binding LOI with Infusion and CHF. The LOI obligates the company to allow them to exchange their existing notes for new Series A that are convertible into a little less than 283 million shares so long as they invest $750K in total. They have already invested $400K towards that amount.
So they are getting a little less than 283 million AVDX shares for less than $.003 a share.
On the same day, GC resigned from the AVDX board.
He probably had too as this completely decimates the AMBS holdings in AVDX.
(2)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links